fig2
From: Cancer Evo-Dev, a novel hypothesis derived from studies on hepatitis B virus-induced carcinogenesis
Figure 2. The HCC-related HBV mutations arehallmark molecular events during HBV-induced carcinogenesis. ASC: asymptomatic HBsAg carrier; CHB: chronic hepatitis B; LC: liver cirrhosis; HBeAg: hepatitis B e antigen; HCC: hepatocellular carcinoma
